Characteristics of Asprosin and Some Biochemical in Prediabetic Pregnant Women Presenting with UTIs
Abstract
Diabetes can exacerbate the infection since pregnant women with diabetes had a higher incidence of UTI (29.9%) than pregnant women without diabetes (11.1%). This study investigated the percentage of patients who had a urinary tract infection (UTI) in order to evaluate the function of paternal genetics in the development of DM and ascertain the effect of DM on the urinary system. The study comprised 90 pregnant women, ages 25 to 50, with and without diabetes mellitus (DM) in comparison to control pregnant women. The blood sugar levels and diabetes mellitus were determined both clinically and in a private, specialized laboratory. There was information on the age, etiology, and family history of diabetes. Bacterial species were isolated and identified using culture media and biochemical assays. Patients with UTIs were mostly female (73%) in proportion. To sum up, type 2 diabetes is the most prevalent, particularly in women, and it rises with age. Family genetic susceptibility and abrupt shocks were the primary causes of diabetes mellitus. The majority of diabetes individuals, particularly women, experienced UTIs, and the primary reasons of UTI inflammation were also shown by the current study. Insulin-resistant mice and humans have pathologically elevated levels of asprosin, a new hormone that has been found to be concentrated in white adipose tissue. However, there is currently no information available about asprosin's involvement in type 2 diabetes mellitus (T2DM). The aim of our study was to determine whether there might connection between prediabetic pregnant women presenting with and circulating asprosin levels.
References
Albrecht, S. S., Kahn, L. G., & Wittenborn, A. K. (2010). Diabetes trends among delivery hospitalizations in the US, 1994–2004. Diabetes Care, 33(4), 768-773. https://doi.org/10.2337/dc09-1606
Alhaj, S., Allami, S., Mohamadiyeh, A., Agha, A., Ali, A. K. A., Habbal, J. M. B., & Saeed, B. Q. (2024). Knowledge, Attitudes, and Practices Regarding Urinary Tract Infections Among Women in the United Arab Emirates. medRxiv, 2024-02. https://doi.org/10.1101/2024.02.05.24302366
Al-Sultan, L. H., & Al-Issa, Y. A. (2023). Estimation of Asprosin hormone in obese Iraqi patients with hypothyroidism. History of Medicine, 9(2), 514-518.
Alwash, S., McIntyre, D., & Mamun, A. (2023). The pre-pregnancy fasting blood glucose, glycated hemoglobin and lipid profiles as blood biomarkers for gestational diabetes mellitus: evidence from a multigenerational cohort study. The Journal of Maternal-Fetal & Neonatal Medicine, 36(1), 2195524. https://doi.org/10.1080/14767058.2023.2195524
Cetin, I., Carlson, S. E., Burden, C., da Fonseca, E. B., di Renzo, G. C., Hadjipanayis, A., ... & Koletzko, B. (2024). Omega-3 fatty acid supply in pregnancy for risk reduction of preterm and early preterm birth. American journal of obstetrics & gynecology MFM, 6(2), 101251. https://doi.org/10.1016/j.ajogmf.2023.101251
Chin, K. L., Sarmiento, M. E., Alvarez-Cabrera, N., Norazmi, M. N., & Acosta, A. (2020). Pulmonary non-tuberculous mycobacterial infections: current state and future management. European Journal of Clinical Microbiology & Infectious Diseases, 39, 799-826. https://doi.org/10.1007/s10096-019-03771-0
Colella, M., Topi, S., Palmirotta, R., D’Agostino, D., Charitos, I. A., Lovero, R., & Santacroce, L. (2023). An overview of the microbiota of the human urinary tract in health and disease: current issues and perspectives. Life, 13(7), 1486. https://doi.org/10.3390/life13071486
Diao, H., Fan, X., Li, Z., Hou, L., Dong, Z., & Pang, S. (2024). Circulating asprosin concentrations in individuals with new-onset type 2 diabetes and prediabetes. Diabetes Research and Clinical Practice, 111730. https://doi.org/10.1016/j.diabres.2024.111730
Diao, H., Li, X., Xu, Y., Xing, X., & Pang, S. (2023). Asprosin, a novel glucogenic adipokine implicated in type 2 diabetes mellitus. Journal of Diabetes and its Complications, 108614. https://doi.org/10.1016/j.jdiacomp.2023.108614
Fageräng, B., Lau, C., Mc Adam, K. E., Schjalm, C., Christiansen, D., Garred, P., ... & Mollnes, T. E. (2024). A novel selective leukocyte depletion human whole blood model reveals the specific roles of monocytes and granulocytes in the cytokine response to Escherichia coli. Journal of Leukocyte Biology, 115(4), 647-663. https://doi.org/10.1093/jleuko/qiad151
Fried, M. (2022). Etiology of Dysuria in both Men and Women. Handbook of Outpatient Medicine, 561.
Fuhler, G. M. (2020). The immune system and microbiome in pregnancy. Best Practice & Research Clinical Gastroenterology, 44, 101671. https://doi.org/10.1016/j.bpg.2020.101671
Hekim, M. G., Kelestemur, M. M., Bulmus, F. G., Bilgin, B., Bulut, F., Gokdere, E., ... & Ozcan, M. (2023). Asprosin, a novel glucogenic adipokine: a potential therapeutic implication in diabetes mellitus. Archives of physiology and biochemistry, 129(5), 1038-1044. https://doi.org/10.1080/13813455.2021.1894178
International Diabetes Federation. (2019). IDF Diabetes Atlas (9th ed.). International Diabetes Federation.
Karunarathna, I., Gunasena, P., Hapuarachchi, T., & Gunathilake, S. (2024). Cefiderocol and cephalosporins: A novel approach to managing resistant Gram-negative bacterial infections.
Kitzmiller, J. L., Buchanan, T. A., & Redmon, J. B. (2008). Managing preexisting diabetes for pregnancy: Summary of evidence and consensus recommendations for care. Diabetes Care, 31(5), 1060-1079. https://doi.org/10.2337/dc08-0205
López Stewart, G. (2014). Diagnostic criteria and classification of hyperglycaemia first detected in pregnancy: A World Health Organization guideline. World Health Organization.
Luo, Y., Qin, Y., Kong, L., Long, J., Lukacs-Kornek, V., Li, J., ... & Qin, J. (2024). Clinical and pathological characteristics of gestational diabetes mellitus with different insulin resistance. Journal of Diabetes and its Complications, 108796. https://doi.org/10.1016/j.jdiacomp.2024.108796
MANDAL, D. (2024). Various Antibiotic Contamination in Natural Sources: Effects on Environment Including Animals and Humans (A-Review). Oriental Journal of Chemistry, 40(2). https://doi.org/10.13005/ojc/400204
Mazur-Bialy, A. I. (2021). Asprosin—a fasting-induced, glucogenic, and orexigenic adipokine as a new promising player. Will it be a new factor in the treatment of obesity, diabetes, or infertility? A review of the literature. Nutrients, 13(2), 620. https://doi.org/10.3390/nu13020620
Mititelu, M., Olteanu, G., Neacșu, S. M., Stoicescu, I., Dumitrescu, D. E., Gheorghe, E., ... & Lupu, C. E. (2024). Incidence of Urinary Infections and Behavioral Risk Factors. Nutrients, 16(3), 446. https://doi.org/10.3390/nu16030446
Mondestin, M. A., Ananth, C. V., Smulian, J. C., & Vintzileos, A. M. (2002). Birth weight and fetal death in the United States: the effect of maternal diabetes during pregnancy. American journal of obstetrics and gynecology, 187(4), 922-926. https://doi.org/10.1067/mob.2002.127458
Nakshine, V. S., & Jogdand, S. D. (2023). A Comprehensive Review of Gestational Diabetes Mellitus: Impacts on Maternal Health, Fetal Development, Childhood Outcomes, and Long-Term Treatment Strategies. Cureus, 15(10). https://doi.org/10.7759/cureus.47500
Nicolaou, V. (2021). The impact of diabetes mellitus in pregnancy on maternal health outcomes. Faculty of Health Sciences, University of the Witwatersrand, Johannesburg.
Noyola-Martínez, N., Halhali, A., & Barrera, D. (2019). Steroid hormones and pregnancy. Gynecological Endocrinology, 35(5), 376-384. https://doi.org/10.1080/09513590.2018.1564742
Pacheco, L. D., & Omere, C. I. (2024). Acute Kidney Injury and Renal Replacement Therapy. Critical Care Obstetrics, 291-304. https://doi.org/10.1002/9781119820260.ch16
Raatz, M., de Azevedo-Lopes, A., Drabik, K., Traulsen, A., & Waclaw, B. (2024). Pathogen non-planktonic phases within the urinary tract impact early infection and resistance evolution. The ISME Journal, 18(1), wrae191. https://doi.org/10.1093/ismejo/wrae191
Rochon, A., Robertson, M., & Carragher, R. (2024). geriatric syndromes and Atypical presentations of Illness. Supporting Older Persons on Their Aging Journey: An Emancipatory Approach to Nursing Care, 229.
Romere, C., Duerrschmid, C., Bournat, J., Constable, P., Jain, M., Xia, F., ... & Chopra, A. R. (2016). Asprosin, a fasting-induced glucogenic protein hormone. Cell, 165(3), 566-579. https://doi.org/10.1016/j.cell.2016.02.063
Savona-Ventura, C., Mahmood, T., Mukhopadhyay, S., & Louwen, F. (2024). Omega-3 fatty acid supply in pregnancy for risk reduction of preterm and early preterm birth: A position statement by the European Board and College of Obstetrics and Gynaecology (EBCOG). European Journal of Obstetrics & Gynecology and Reproductive Biology, 295, 124-125. https://doi.org/10.1016/j.ejogrb.2024.02.009
Shabir, K., Brown, J. E., Afzal, I., Gharanei, S., Weickert, M. O., Barber, T. M., ... & Randeva, H. S. (2021). Asprosin, a novel pleiotropic adipokine implicated in fasting and obesity-related cardio-metabolic disease: Comprehensive review of preclinical and clinical evidence. Cytokine & Growth Factor Reviews, 60, 120-132. https://doi.org/10.1016/j.cytogfr.2021.05.002
Wondmkun, Y. T. (2020). Obesity, insulin resistance, and type 2 diabetes: associations and therapeutic implications. Diabetes, Metabolic Syndrome and Obesity, 3611-3616. https://doi.org/10.2147/DMSO.S275898
Ysrraelit, M. C., & Correale, J. (2019). Impact of sex hormones on immune function and multiple sclerosis development. Immunology, 156(1), 9-22. https://doi.org/10.1111/imm.13004
Copyright (c) 2024 Journal La Lifesci
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
